Support for emerging synthetic biology companies
Working in academia, with plans to launch a synthetic biology company within the next 2 years? Or in business for under 5 years with fewer than 50 employees? During 2018, the Synthetic Biology Division at IDT will award 2 Synthetic Biology Start-up Grants—for gene fragments, genes or CRISPR product credit (the equivalent of 100 KB for the grant winner, and 50 KB of gBlocks® Gene Fragments for the runner-up). Awards will go to US-based start-up companies working in the areas of human health, sustainable manufacturing, or humanitarian causes, such as world hunger, disease control, and sustainable farming. The IDT Synthetic Biology Start-up Grants are intended to help emerging companies that are in their earliest stages of growth.
IDT established the Synthetic Biology Start-up Grant Program to help researchers evolve their scientific ideas into impactful, real-world solutions. We also provide support and guidance for young scientists participating in the annual iGEM (International Genetically Engineered Machine) competition. In addition, the annual IDT Sustainability Award recognizes and provides funding for innovative academic research projects that use IDT products and have the potential to make a global impact in the area of biodiversity.
The world’s leading manufacturer of nucleic acids, IDT has developed a family of high quality, novel reagents that expedite gene assembly, cloning, mutagenesis and CRISPR genome editing experiments. Among these are gBlocks® Gene Fragments, Megamer® Single-Stranded DNA Fragments, Alt-R® CRISPR enzymes, Alt-R CRISPR-Cas9 and Alt-R CRISPR-Cpf1 genome editing systems, and the Alt-R Genome Editing Detection Kit. Invaluable to many current synthetic biology and genome editing applications, these are some of the products that qualify for grant awardee product credit.
Learn more about synthetic biology at IDT, and our CRISPR genome editing products.
Winning companies will be profiled to the worldwide research community
In addition to product credit, IDT Synthetic Biology Start-up Grant recipients will be featured in a video and have a chance to present their winning project to over 110,000 scientists who subscribe to the IDT DECODED newsletter.
Are YOU eligible?
Qualifying companies must be based in the United States, and have been in business for under 5 years with fewer than 50 employees. Academics with plans to launch a synthetic biology company within the next 2 years are also eligible. Applications will be accepted from June 18 through August 1, 2018. Grant winners will be contacted in September, with a public announcement in November, 2018. Will your company be the next winner?
Learn more details about applicant criteria and the application process here.